English  |  正體中文  |  简体中文  |  总笔数 :0  
造访人次 :  51632543    在线人数 :  945
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

"felip e"的相关文件

回到依作者浏览
依题名排序 依日期排序

显示项目 21-30 / 44 (共5页)
<< < 1 2 3 4 5 > >>
每页显示[10|25|50]项目

机构 日期 题名 作者
臺大學術典藏 2020-05-26T09:26:41Z A randomized, open-label, multicenter, phase 3 study to compare the efficacy and safety of eribulin to treatment of physician's choice in patients with advanced non-small cell lung cancer Barlesi F.;Satouchi M;Iannotti N;Chih-Hsin Yang;Nokihara H;Guo M;Olivo M;Kim J.-H;Spigel D.R;Felip E;Katakami N; Katakami N; Felip E; Spigel D.R; Kim J.-H; Olivo M; Guo M; Nokihara H; CHIH-HSIN YANG; Iannotti N; Satouchi M; Barlesi F.
臺大學術典藏 2020-05-26T09:26:41Z A randomized, open-label, multicenter, phase 3 study to compare the efficacy and safety of eribulin to treatment of physician's choice in patients with advanced non-small cell lung cancer Barlesi F.;Satouchi M;Iannotti N;Chih-Hsin Yang;Nokihara H;Guo M;Olivo M;Kim J.-H;Spigel D.R;Felip E;Katakami N; Katakami N; Felip E; Spigel D.R; Kim J.-H; Olivo M; Guo M; Nokihara H; CHIH-HSIN YANG; Iannotti N; Satouchi M; Barlesi F.
臺大學術典藏 2020-05-26T09:26:40Z The Potential of Combined Immunotherapy and Antiangiogenesis for the Synergistic Treatment of Advanced NSCLC Syrigos K; van Meerbeeck J.P; van Zandwijk N; Chih-Hsin CHIH-HSIN YANG; Zhou C; Vokes E.; Vokes E.;Zhou C;Chih-Hsin Yang;Van Zandwijk N;Van Meerbeeck J.P;Syrigos K;Smit E.F;P?rol M;Papotti M;Novello S;Mornex F;Moniuszko M;Marabelle A;Huber R.M;Garrido P;Fennell D;Felip E;Crin? L;Brustugun O.T;Wu Y.-L;Reck M;Peters S;Nicolson M;Nakagawa K;Gray J.E;Dingemans A.-M.C;Manegold C; Manegold C; Dingemans A.-M.C; Gray J.E; Nakagawa K; Nicolson M; Peters S; Reck M; Wu Y.-L; Brustugun O.T; Crinò L; Felip E; Smit E.F; Pérol M; Papotti M; Fennell D; Garrido P; Huber R.M; Marabelle A; Moniuszko M; Mornex F; Novello S
臺大學術典藏 2020-05-26T09:26:40Z The Potential of Combined Immunotherapy and Antiangiogenesis for the Synergistic Treatment of Advanced NSCLC Syrigos K; van Meerbeeck J.P; van Zandwijk N; Chih-Hsin CHIH-HSIN YANG; Zhou C; Vokes E.; Vokes E.;Zhou C;Chih-Hsin Yang;Van Zandwijk N;Van Meerbeeck J.P;Syrigos K;Smit E.F;P?rol M;Papotti M;Novello S;Mornex F;Moniuszko M;Marabelle A;Huber R.M;Garrido P;Fennell D;Felip E;Crin? L;Brustugun O.T;Wu Y.-L;Reck M;Peters S;Nicolson M;Nakagawa K;Gray J.E;Dingemans A.-M.C;Manegold C; Manegold C; Dingemans A.-M.C; Gray J.E; Nakagawa K; Nicolson M; Peters S; Reck M; Wu Y.-L; Brustugun O.T; Crinò L; Felip E; Smit E.F; Pérol M; Papotti M; Fennell D; Garrido P; Huber R.M; Marabelle A; Moniuszko M; Mornex F; Novello S
臺大學術典藏 2020-05-26T09:26:38Z Osimertinib in pretreated T790M-positive advanced non-small-cell lung cancer: AURA study phase II extension component J?nne P.A.;Ghiorghiu S;Cantarini M;Mann H;Lin C.-C;Hirashima T;Gold K;Novello S;Yoh K;Haggstrom D;Blackhall F;Felip E;Planchard D;Kim J.-H;Kim S.-W;Su W.-C;Sequist L.V;Ramalingam S.S;Kim D.-W;Ahn M.-J;Chih-Hsin Yang; CHIH-HSIN YANG; Ahn M.-J; Kim D.-W; Ramalingam S.S; Sequist L.V; Su W.-C; Kim S.-W; Kim J.-H; Planchard D; Felip E; Blackhall F; Haggstrom D; Yoh K; Novello S; Gold K; Hirashima T; Lin C.-C; Mann H; Cantarini M; Ghiorghiu S; Jänne P.A.
臺大學術典藏 2020-05-26T09:26:38Z Osimertinib in pretreated T790M-positive advanced non-small-cell lung cancer: AURA study phase II extension component J?nne P.A.;Ghiorghiu S;Cantarini M;Mann H;Lin C.-C;Hirashima T;Gold K;Novello S;Yoh K;Haggstrom D;Blackhall F;Felip E;Planchard D;Kim J.-H;Kim S.-W;Su W.-C;Sequist L.V;Ramalingam S.S;Kim D.-W;Ahn M.-J;Chih-Hsin Yang; CHIH-HSIN YANG; Ahn M.-J; Kim D.-W; Ramalingam S.S; Sequist L.V; Su W.-C; Kim S.-W; Kim J.-H; Planchard D; Felip E; Blackhall F; Haggstrom D; Yoh K; Novello S; Gold K; Hirashima T; Lin C.-C; Mann H; Cantarini M; Ghiorghiu S; Jänne P.A.
臺大學術典藏 2020-05-26T09:26:31Z CNS response to osimertinib in patients with T790M-positive advanced NSCLC: Pooled data from two phase II trials Jänne P.A; CHIH-HSIN YANG; Mitsudomi T; Johnson M; Cantarini M; Chih-Hsin Yang;J?nne P.A;Mitsudomi T;Johnson M;Cantarini M;Hodge R;Morabito A;Felip E;De Marinis F;Crin? L;Bazhenova L;Ahn M.-J;Shepherd F.A;Tsai C.-M;Goss G; Goss G; Tsai C.-M; Shepherd F.A; Ahn M.-J; Bazhenova L; Crinò L; de Marinis F; Felip E; Morabito A; Hodge R
臺大學術典藏 2020-05-26T09:26:31Z CNS response to osimertinib in patients with T790M-positive advanced NSCLC: Pooled data from two phase II trials Jänne P.A; CHIH-HSIN YANG; Mitsudomi T; Johnson M; Cantarini M; Chih-Hsin Yang;J?nne P.A;Mitsudomi T;Johnson M;Cantarini M;Hodge R;Morabito A;Felip E;De Marinis F;Crin? L;Bazhenova L;Ahn M.-J;Shepherd F.A;Tsai C.-M;Goss G; Goss G; Tsai C.-M; Shepherd F.A; Ahn M.-J; Bazhenova L; Crinò L; de Marinis F; Felip E; Morabito A; Hodge R
臺大學術典藏 2020-05-26T09:26:25Z Phase Ib/II Study of Capmatinib (INC280) Plus Gefitinib after Failure of Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy in Patients with EGFR-Mutated, MET Factor-Dysregulated Non-Small-Cell Lung Cancer Tan D.S.W.;Akimov M;Peng B;Zhao S;Pultar P;Glaser S;Chia V;Felip E;Su W.-C;Vansteenkiste J.F;Ahn M.-J;Chih-Hsin Yang;Lee D.H;Liu X;Kim D.-W;Zhang L;Wu Y.-L; Wu Y.-L; Zhang L; Kim D.-W; Liu X; Lee D.H; CHIH-HSIN YANG; Ahn M.-J; Vansteenkiste J.F; Su W.-C; Felip E; Chia V; Glaser S; Pultar P; Zhao S; Peng B; Akimov M; Tan D.S.W.
臺大學術典藏 2020-05-26T09:26:25Z Phase Ib/II Study of Capmatinib (INC280) Plus Gefitinib after Failure of Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy in Patients with EGFR-Mutated, MET Factor-Dysregulated Non-Small-Cell Lung Cancer Tan D.S.W.;Akimov M;Peng B;Zhao S;Pultar P;Glaser S;Chia V;Felip E;Su W.-C;Vansteenkiste J.F;Ahn M.-J;Chih-Hsin Yang;Lee D.H;Liu X;Kim D.-W;Zhang L;Wu Y.-L; Wu Y.-L; Zhang L; Kim D.-W; Liu X; Lee D.H; CHIH-HSIN YANG; Ahn M.-J; Vansteenkiste J.F; Su W.-C; Felip E; Chia V; Glaser S; Pultar P; Zhao S; Peng B; Akimov M; Tan D.S.W.

显示项目 21-30 / 44 (共5页)
<< < 1 2 3 4 5 > >>
每页显示[10|25|50]项目